Latest news
JD Health Launches 65 New Drugs in H1, Leveraging Grassroots Penetration and AI Services as Competitive Moat - finance.biggo.comfinance.biggo.com · Fri, 07 Aug 2026 13:35:00 GMTSK Biopharmaceuticals Establishes Dedicated IP Defense Unit for Xcopri, Bracing for Generic and New Drug Competition - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 07:06:00 GMTBeyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 15:17:36 GMT